Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 400 | 0 | 0 | 0 |
| Cost of Goods | 488 | N/A | N/A | N/A | N/A |
| Gross Profit | -488 | 400 | N/A | N/A | N/A |
| Operating Expenses | 24,018 | 23,192 | 19,727 | 16,672 | 15,345 |
| Operating Income | -24,018 | -22,792 | -19,727 | -16,672 | -15,345 |
| Interest Expense | 901 | 957 | 998 | 1,082 | 1,102 |
| Other Income | 4,561 | 148,094 | 8,696 | 8,461 | -13,822 |
| Pre-tax Income | -20,358 | 124,345 | -12,029 | -9,293 | -30,269 |
| Income Tax | -15,197 | 15,512 | N/A | N/A | N/A |
| Net Income Continuous | -5,161 | 108,833 | -12,029 | -9,293 | -30,269 |
| Net Income | $-5,161 | $108,833 | $-12,029 | $-9,293 | $-30,269 |
| EPS Basic Total Ops | -0.10 | 2.07 | -0.24 | 0.05 | -0.63 |
| EPS Basic Continuous Ops | -0.10 | 2.07 | -0.24 | 0.05 | -0.63 |
| EPS Diluted Total Ops | -0.10 | 1.71 | -0.24 | 0.50 | -0.63 |
| EPS Diluted Continuous Ops | -0.10 | 1.63 | -0.24 | 0.09 | -0.63 |
| EPS Diluted Before Non-Recurring Items | -0.10 | 1.71 | -0.24 | -0.24 | -0.31 |
| EBITDA(a) | $-23,130 | $-22,024 | $-18,912 | $-15,896 | $-14,623 |